Journal
RHEUMATOLOGY
Volume 42, Issue 4, Pages 522-527Publisher
OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keg168
Keywords
biglycan; decorin; aggrecan; collagen; fibronectin; antibody; RA
Categories
Ask authors/readers for more resources
Objectives. To determine whether patients with rheumatoid arthritis (RA) express Immoral immunity to the small proteoglycans biglycan and decorin and to compare the response to that of patients suffering from other joint diseases. Methods. Serum and synovial fluid IgG and IgM antibody levels were determined by enzyme-linked immunosorbent assay. Antibodies to biglycan and decorin as well as to other known and extensively investigated cartilage matrix components such as type II collagen, aggrecan and fibronectin were investigated. Patients suffering from RA, osteoarthritis (OA), psoriatic arthritis and other seronegative spondylarthropathies were included in the study. Correlation between antibody levels and clinical/laboratory parameters was determined. Results. Patients with RA expressed an increased Immoral immunity to biglycan, while patients with seronegative spondylarthropathies displayed elevated decorin-specific synovial antibody levels compared with OA patients. Conclusion. These results indicate a significantly higher immunity to small proteoglycans; in RA and seronegative spondylarthropathies than in OA suggesting a possible involvement in the pathogenesis of inflammatory rheumatic diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available